Nintedanib offered no significant advantage over placebo in patients with interstitial lung disease (ILD) following a severe SARS-CoV-2 infection. No significant differences were observed between ...
AI tools are proliferating across pulmonary medicine and critical care, with promising early results in diagnostics and ...
The Oscar winner is honoring her mother’s legacy by teaching women to fight for better care from their doctors.
The PRILD scoring system can help in the systematic assessment of thoracic involvement in rheumatologic-related ILD.
Targeting effective control of rheumatoid arthritis disease activity is crucial component of treatment strategy.
People living with interstitial lung disease (ILD) are especially vulnerable during extreme heat. As climate change drives more frequent and intense heatwaves, people with ILD will need better ...
Researchers have validated a genetic scoring tool that may help physicians diagnose idiopathic pulmonary fibrosis and identify which patients are at greatest risk for severe outcomes, including death ...
Pulmonary fibrosis is a deadly disease in which scar tissue grows in the lungs, making breathing more difficult.
Rheumatoid arthritis is associated with increased respiratory-related mortality in non-tuberculosis mycobacterial pulmonary ...
Background Protein availability critically influences innate immune reactivity and the extent of immune-mediated tissue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results